Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Signs and Causes of Binocular Vision Dysfunction
Binocular vision refers to the ability of the eyes to work together as a team to perceive depth and perceive a single image. Binocular vision is graded based on the degree of deviation or misalignment between the two eyes. Grades…
Oxular’s OXU-001 Receives IND Acceptence
The U.S. Food and Drug Administration has approved Oxular Limited’s investigational new drug application (IND) for suprachoroidal OXU-001 for the treatment of diabetic macular edema (DME). The IND permits the OXEYE Phase 2 trial to proceed, which will assess the…
Dacryoadenitis: Causes, Symptoms and Treatment
What Is Dacryoadenitis? Dacryoadenitis is an inflammatory condition that specifically targets the lacrimal glands, the glands responsible for tear production. Located in the upper outer region of each eye, these glands play an essential role in maintaining eye health by…
What Is Capsulorhexis and How It’s Done
What Is Capsulorhexis? Capsulorhexis, derived from the Latin “capsula” (little container) and Greek “rhexis” (rupture), refers to the precise and controlled tear of the anterior lens capsule during cataract surgery. This procedure creates a circular opening through which the cloudy…
All About Phacoemulsification Procedure | OBN
The phacoemulsification procedure has transformed cataract surgery, offering a less invasive and more efficient method for cataract removal. This advanced surgical technique uses ultrasonic vibrations to emulsify the cloudy lens, which is then aspirated out and replaced with an artificial…
GenSight Withdraws Application for Lumevoq in Europe
GenSight Biologics announced that it is withdrawing its application submitted to the European Medicines Agency (EMA) seeking approval for Lumevoq (lenadogene nolparvovec) in patients with Leber hereditary optic neuropathy (LHON). The decision comes after the Committee for Advanced Therapies (CAT)…
California Approves Expanded Scope of Practice Legislation
SACRAMENTO, Calif.—Two bills signed into law recently by Calif. Gov. Gavin Newsom will expand the scope of practice for optometrists in the state, according to a recent announcement by the California Optometric Association (COA). AB 407: Expanded Treatment for Non-Cancerous Anterior Segment…
Théa Obtains Sepofarsen and Ultevursen from ProQR
ProQR Therapeutics and Laboratoires Théa have reached an agreement through which ProQR will transfer its advanced ophthalmic assets, sepofarsen and ultevursen, to Théa. Under the terms of the agreement, ProQR will secure an initial payment totaling €12.5 million ($13.7 million).…
Alcon and Ivantis Lose Patent Battle to Sight Sciences.
Sight Sciences announced its success in defeating all four patent invalidity challenges that were filed against it by Alcon and Ivantis in the United States Patent and Trademark Office. Patent Infringement Litigation Over Hydrus® Microstent In September 2021, Sight Sciences…
Brim Biotech’s Clinical Trial for DED Kicks Off
BRIM Biotechnology has initiated the Phase 3 clinical trial of BRM421 for the treatment of Dry Eye Disease (DED) and enrolled the first patient in the trial. This multicenter, double-blind, randomized, vehicle-controlled trial will enroll over 700 patients with moderate…